Other Species / Isoforms
  TXN (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
V2-n-ub
______MvkQIESkt
0 1
TXN (human) ______MvkQIESkt V2-n-ub
TXN (mouse) ______MVKLIESkE V2
TXN (rat) ______MVkLIESkE V2
K3-ac
_____MvkQIESktA
0 3
TXN (human) _____MvkQIESktA K3-ac
TXN (mouse) _____MVKLIESkEA K3
TXN (rat) _____MVkLIESkEA K3-ac
K3-ub
_____MvkQIESktA
0 1
TXN (human) _____MvkQIESktA K3-ub
TXN (mouse) _____MVKLIESkEA K3
TXN (rat) _____MVKLIESkEA K3
K8-ac
MvkQIESktAFQEAL
0 4
TXN (human) MvkQIESktAFQEAL K8-ac
TXN (mouse) MVKLIESkEAFQEAL K8-ac
TXN (rat) MVkLIESkEAFQEAL K8-ac
K8-ub
MvkQIESktAFQEAL
0 3
TXN (human) MvkQIESktAFQEAL K8-ub
TXN (mouse) MVKLIESkEAFQEAL K8-ub
TXN (rat) MVkLIESKEAFQEAL K8
K8-m1
MvkQIESktAFQEAL
0 1
TXN (human) MvkQIESktAFQEAL K8-m1
TXN (mouse) MVKLIESKEAFQEAL K8
TXN (rat) MVkLIESKEAFQEAL K8
K8-sc
MvkQIESktAFQEAL
0 1
TXN (human) MvkQIESktAFQEAL K8-sc
TXN (mouse) MVKLIESkEAFQEAL K8-sc
TXN (rat) MVkLIESKEAFQEAL K8
T9-p
vkQIESktAFQEALD
0 2
TXN (human) vkQIESktAFQEALD T9-p
TXN (mouse) VKLIESkEAFQEALA E9
TXN (rat) VkLIESkEAFQEALA E9
T30-p
VVVDFSAtWCGPCKM
0 1
TXN (human) VVVDFSAtWCGPCKM T30-p
TXN (mouse) VVVDFSATWCGPCKM T30
TXN (rat) VVVDFSATWCGPCKM T30
K39-ac
CGPCKMIkPFFHsLs
0 14
TXN (human) CGPCKMIkPFFHsLs K39-ac
TXN (mouse) CGPCKMIkPFFHsLC K39-ac
TXN (rat) CGPCKMIkPFFHSLC K39-ac
K39-ub
CGPCKMIkPFFHsLs
0 7
TXN (human) CGPCKMIkPFFHsLs K39-ub
TXN (mouse) CGPCKMIkPFFHsLC K39-ub
TXN (rat) CGPCKMIKPFFHSLC K39
K39-sc
CGPCKMIkPFFHsLs
0 1
TXN (human) CGPCKMIkPFFHsLs K39-sc
TXN (mouse) CGPCKMIKPFFHsLC K39
TXN (rat) CGPCKMIKPFFHSLC K39
S44-p
MIkPFFHsLsEkYSN
0 4
TXN (human) MIkPFFHsLsEkYSN S44-p
TXN (mouse) MIkPFFHsLCDKYSN S44-p
TXN (rat) MIkPFFHSLCDKYSN S44
S46-p
kPFFHsLsEkYSNVI
0 2
TXN (human) kPFFHsLsEkYSNVI S46-p
TXN (mouse) kPFFHsLCDKYSNVV C46
TXN (rat) kPFFHSLCDKYSNVV C46
K48-m1
FFHsLsEkYSNVIFL
0 1
TXN (human) FFHsLsEkYSNVIFL K48-m1
TXN (mouse) FFHsLCDKYSNVVFL K48
TXN (rat) FFHSLCDKYSNVVFL K48
S67-p
DDCQDVAsECEVKCM
0 1
TXN (human) DDCQDVAsECEVKCM S67-p
TXN (mouse) DDCQDVAADCEVKCM A67
TXN (rat) DDCQDVAADCEVKCM A67
T76-p
CEVKCMPtFQFFkKG
Upstream
Downstream
1 1
Effects on Modified Protein
  • enzymatic activity, inhibited
  • protein degradation
  • ubiquitination
Effects on Biological Processes:
  • apoptosis, inhibited
  • signaling pathway regulation
  • transcription, inhibited
Kinase, in vitro:
  • MELK (mouse)
Putative in vivo kinases:
  • MELK (mouse)
Treatment
  • DNCB
TXN (human) CEVKCMPtFQFFkKG T76-p
TXN (mouse) CEVKCMPTFQFYkKG T76
TXN (rat) CEVKCMPTFQFYKKG T76
K81-ac
MPtFQFFkKGQkVGE
0 5
TXN (human) MPtFQFFkKGQkVGE K81-ac
TXN (mouse) MPTFQFYkKGQKVGE K81-ac
TXN (rat) MPTFQFYKKGQKVGE K81
K85-ub
QFFkKGQkVGEFsGA
0 1
TXN (human) QFFkKGQkVGEFsGA K85-ub
TXN (mouse) QFYkKGQKVGEFSGA K85
TXN (rat) QFYKKGQKVGEFSGA K85
K85-sc
QFFkKGQkVGEFsGA
0 1
TXN (human) QFFkKGQkVGEFsGA K85-sc
TXN (mouse) QFYkKGQKVGEFSGA K85
TXN (rat) QFYKKGQKVGEFSGA K85
S90-p
GQkVGEFsGANkEkL
0 2
TXN (human) GQkVGEFsGANkEkL S90-p
TXN (mouse) GQKVGEFSGANkEkL S90
TXN (rat) GQKVGEFSGANkEkL S90
K94-ac
GEFsGANkEkLEAtI
0 6
TXN (human) GEFsGANkEkLEAtI K94-ac
TXN (mouse) GEFSGANkEkLEASI K94-ac
TXN (rat) GEFSGANkEkLEATI K94-ac
K94-ub
GEFsGANkEkLEAtI
0 3
TXN (human) GEFsGANkEkLEAtI K94-ub
TXN (mouse) GEFSGANKEkLEASI K94
TXN (rat) GEFSGANKEkLEATI K94
K94-sc
GEFsGANkEkLEAtI
0 1
TXN (human) GEFsGANkEkLEAtI K94-sc
TXN (mouse) GEFSGANKEkLEASI K94
TXN (rat) GEFSGANKEkLEATI K94
K96-ac
FsGANkEkLEAtINE
0 10
TXN (human) FsGANkEkLEAtINE K96-ac
TXN (mouse) FSGANkEkLEASITE K96-ac
TXN (rat) FSGANkEkLEATITE K96-ac
K96-ub
FsGANkEkLEAtINE
0 13
TXN (human) FsGANkEkLEAtINE K96-ub
TXN (mouse) FSGANkEkLEASITE K96-ub
TXN (rat) FSGANkEKLEATITE K96
T100-p
NkEkLEAtINELV__
Upstream
Downstream
1 1
Effects on Modified Protein
  • intracellular localization
Effects on Biological Processes:
  • apoptosis, altered
Putative in vivo kinases:
  • PKCA (human)
Treatment
  • adriamycin
  • cisplatin
  • phorbol_ester
  • serum
  • staurosporine
TXN (human) NkEkLEAtINELV__ T100-p
TXN (mouse) NkEkLEASITEYA__ S100
TXN (rat) NkEkLEATITEFA__ T100